Journal of Pediatric Article Review: June 2023, AAP Issue
With Dr. Colin Martin & Dr. Brad Warner & Dr. Andrew Fleming · hosted by Dr. Cecilia Gigena & Dr. Em Tombash & Dr. Todd Ponsky · StayCurrentMD
Cued at 10:43 · stops at 11:28 · press play
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Outcomes of Children With Short Bowel Syndrome: Experiences in a Multidisciplinary Intestinal Rehabilitation Unit Over Two Decades
45 s · Published Mar 2025
Video
Impact of social determinants of health on outcomes in pediatric short bowel syndrome...
43 s · Published Aug 2026
Podcast
Intestinal Rehabilitation Episode 8: Refeeding of an Older Patient
12 min · Published Oct 2023
Video
Intestinal Rehabilitation Webinar 2023 - Top 5 Key Takeaways
CCHMC Pediatric Surgery · 12 min · Published Jun 2024
Video
Quick Literature Updates Episode 7
Published May 2023
Podcast
Intestinal Rehabilitation, Episode 7: Refeeding in a neonatal patient
16 min · Published Sep 2023
Only a few other public items share this expert — go deeper there →
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said
The ileocecal region may not be important to preserve in short bowel syndrome and may actually be injurious
Administration of a specific bile acid that is more lipophilic and hepatoprotective could be potential therapy for patients with cholestatic liver disease after massive intestinal resection
In clinical practice, surgeons cannot choose which intestinal segment to remove - they must remove what is dead and preserve as much viable bowel as possible
Once NED status was achieved, 10-year overall survival among high-risk hepatoblastoma patients was similar to patients who were not high-risk
There is no threshold for disease burden that precludes aggressive pursuit of no-evidence-of-disease status in children with hepatoblastoma
Having a formal aerodigestive team is the way to ensure esophageal atresia surveillance gets done
Proximal small bowel resection results in greater oxidative stress in the liver, evidenced by elevated mRNA transcripts for tumor necrosis factor alpha, NADPH oxidase, and glutathione synthase with greater compensatory antioxidant response
46 of 50 hepatoblastoma patients underwent resection using adjuvant techniques including total hepatic vascular exclusion, vascular reconstruction, biliary reconstruction, or en-bloc resection and total hepatectomy with transplantation
82% (41 of 50) of hepatoblastoma patients were able to achieve no-evidence-of-disease (NED) status
14 high-risk hepatoblastoma patients underwent a median of 2.5 pulmonary metastasectomies (7 for unilateral disease, 7 for bilateral disease) with a median of 4.5 nodules resected
5 high-risk hepatoblastoma patients relapsed and 3 of them were saved; NED status was inversely correlated with 5-year mortality
The esophageal atresia surveillance survey had a 77% response rate from 181 physicians at 19 institutions
Only 36% of institutions perform routine upper GI endoscopy in esophageal atresia patients regardless of symptoms, despite evidence showing these patients should be surveilled
Without proper surveillance, esophageal atresia patients could be at risk for esophageal cancer and chronic dysmotility as they survive into adulthood